Visceral adipose tissue has been proposed to mediate obesity-related unfavourable levels of insulin, glucose and lipids, but subcutaneous abdominal adipose tissue has been shown to be independent risk factor for the metabolic complications of obesity [29–31]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.